Skip to main content
. 2017 Oct 11;29(1):250–255. doi: 10.1093/annonc/mdx642

Figure 2.

Figure 2.

Initial grade 2 rash (not shown) with combination therapy progressing to grade 3 rash with anti-programmed death 1 (PD-1) rechallenge (A) followed by desquamation and fatal Stevens–Johnson Syndrome (B and C).